I. Pasanen

Stromal cells of mesenchymal origin in breast cancer

I. Pasanen, 2017 .

Distribution of clodronate in the bone of adult rats and its effects on trabecular and cortical bone.

I. Pasanen, K. Kippo, R. Hannuniemi, 1997, The Journal of pharmacology and experimental therapeutics.

Breast cancer carcinoma-associated fibroblasts differ from breast fibroblasts in immunological and extracellular matrix regulating pathways.

P. Lehenkari, R. Sormunen, M. Pietilä, 2016, Experimental cell research.

Mesenchymal Stromal Cells from Female Donors Enhance Breast Cancer Cell Proliferation in vitro

R. Blanco Sequeiros, P. Lehenkari, T. Hakkarainen, 2014, Oncology.

Tumor tissue inhibitor of metalloproteinases-1 (TIMP-1) in hormone-independent breast cancer might originate in stromal cells, and improves stratification of prognosis together with nodal status.

Y. Soini, P. Lehenkari, T. Hurskainen, 2012, Experimental cell research.

A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis

I. Pasanen, K. Kippo, R. Hannuniemi, 1997, Inflammation Research.

Long-Term Administration of Clodronate Does Not Prevent Fracture Healing in Rats

K. Väänänen, T. Jämsä, J. Tuukkanen, 2003, Clinical orthopaedics and related research.

Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.

K. Väänänen, I. Pasanen, K. Kippo, 1997, The Journal of pharmacology and experimental therapeutics.

Clodronate Prevents Bone Loss in Aged Ovariectomized Rats

H. Väänänen, Z. Peng, I. Pasanen, 1997, Calcified Tissue International.